FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

39833011000001108: Meningococcal group W135 oligosaccharide protein conjugate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jul 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1909501000001113 Meningococcal group W135 oligosaccharide protein conjugate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1909521000001118 Meningococcal group W135 oligosaccharide protein conjugate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Meningococcal group W135 oligosaccharide protein conjugate Is a Meningococcal antibody false Inferred relationship Existential restriction modifier
Meningococcal group W135 oligosaccharide protein conjugate Is a Antigen of Neisseria meningitidis true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Meningococcal oligosaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials Has specific active ingredient True Meningococcal group W135 oligosaccharide protein conjugate Inferred relationship Existential restriction modifier
Meningococcal oligosaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials 1 vial Has specific active ingredient True Meningococcal group W135 oligosaccharide protein conjugate Inferred relationship Existential restriction modifier
Menveo vaccine powder and solvent for solution for injection 0.5ml vials (Novartis Vaccines and Diagnostics Ltd) Has specific active ingredient True Meningococcal group W135 oligosaccharide protein conjugate Inferred relationship Existential restriction modifier
Menveo vaccine powder and solvent for solution for injection 0.5ml vials (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Meningococcal group W135 oligosaccharide protein conjugate Inferred relationship Existential restriction modifier
Menveo vaccine powder and solvent for solution for injection 0.5ml vials (Novartis Vaccines and Diagnostics Ltd) 1 vial Has specific active ingredient True Meningococcal group W135 oligosaccharide protein conjugate Inferred relationship Existential restriction modifier
Menveo vaccine powder and solvent for solution for injection 0.5ml vials (Mawdsley-Brooks & Company Ltd) 1 vial Has specific active ingredient True Meningococcal group W135 oligosaccharide protein conjugate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start